Buy Products not in the Philippines

Galleon.PH - Discover, Share, Buy!
2019 Nelson's Pediatric Antimicrobial Therapy
2019 Nelson's Pediatric Antimicrobial Therapy
2019 Nelson's Pediatric Antimicrobial Therapy

2019 Nelson's Pediatric Antimicrobial Therapy

Product ID : 39828663

Galleon Product ID 39828663
Shipping Weight 0.6 lbs
I think this is wrong?
Manufacturer American Academy Of Pediatrics
Shipping Dimension 6.77 x 5 x 0.79 inches
I think this is wrong?
Save 8%
Before ₱ 2,965

*Price and Stocks may change without prior notice
  • 3 Day Return Policy
  • All products are genuine and original
  • Cash On Delivery/Cash Upon Pickup Available

Pay with

About 2019 Nelson's Pediatric Antimicrobial Therapy

Product Description This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of all infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobials and include complete information about dosing regimens. In response to growing concerns about overuse of antibiotics, the program includes guidelines on when not to prescribe antibiotics. Now in color to help you find the best options quickly! New in the 25th edition: •    Includes recommendations for new intravenous broad-spectrum beta-lactam/beta-lactamase inhibitor combinations. •    Provides options for treatment of increasing resistance in Escherichia coli for urinary tract infections. •    Includes updates for management of diarrhea, including recommendations for Giardia with tinidazole and nitazoxanide as drugs of choice, based on the new Infectious Diseases Society of America (IDSA) guidelines. •    Clarifies specific, new, and evolving recommendations about antifungal therapeutic drug levels for several invasive fungal infections, particularly in immunocompromised children. •    Reorganizes antiviral table for easier reading: common viral pathogens are in one table and HIV, hepatitis B, and hepatitis C are in a second table. •    Provides guidance for neonates during the ongoing cefotaxime shortage, including alternatives to achieve similar antibacterial activity in similar tissue sites, with a similar safety profile. •    Includes updates, such as new information on drug therapy and steroid therapy for neurocysticercosis, incorporating the new IDSA and American Society of Tropical Medicine and Hygiene guidelines. •    Incorporates new IDSA coccidioidomycosis guidelines in updated recommendations. •    Simplifies navigation with color-coded tabs and tables that make it easier to find the best treatment options for susceptibility of bacterial, fungal, viral, and parasitic pathogens. Review 4-Star Review Doody’s Book ReviewsTM “This is a highly valuable resource for any clinician taking care of children with infections from the community to the ICU. This book easily fits into a lab coat pocket, and when a diagnosis or pathogen is known, pulled out to look up the treatment with dosing within minutes.”   Victoria Konold, MD University of Chicago Pritzker School of Medicine       About the Author Elizabeth D. Barnett, MD, FAAP Dr. Elizabeth Barnett is Professor of Pediatrics at Boston University School of Medicine and Attending Physician at Boston Medical Center where she is Director of the Refugee Health Assessment Program and the International Clinic. Her clinical and research interests are general pediatric infectious diseases, immigrant and refugee medicine, travel medicine, and vaccines and vaccine safety. She is a Site Director for GeoSentinel (a global surveillance network for travel and migration associated health issues).   Joseph B. Cantey, MD, FAAP  Joseph B. Cantey, MD, is an Assistant Professor of Pediatrics in the Divisions of Pediatric Infectious Diseases and Neonatology/Perinatal Medicine at the University of Texas Health Science Center in San Antonio. He attended medical school at the Medical University of South Carolina before completing his pediatric residency at Johns Hopkins. He then completed dual fellowships in pediatric infectious diseases and neonatal/perinatal medicine at the University of Texas Southwestern in Dallas, Texas. His research interests include antimicrobial stewardship and responsible prescribing in the nursery setting; infection control and prevention in the nursery setting; and the pathogenesis, diagnosis, treatment, and longitudinal follow-up of congenital and perinatal infections, particularly herpes simplex virus, cytomegalovirus, an